Home | Business News | Browse by Publication | N | Nanotechnology Business Journal

NanoViricides, Inc. Anti-Herpes Drug Candidate Reduces Viral Load by 99.99%.

Publication: Nanotechnology Business Journal
Publication Date: 24-AUG-09
Format: Online
Delivery: Immediate Online Access

Article Excerpt
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced that the herpes simplex viral load was reduced by 99.99% or 10,000 fold in in-vitro studies by nanoviricides™ drug candidates. The studies were performed by Thevac in Baton Rouge, LA, in collaboration with the Division of Biotechnology and Molecular Medicine at the LSU School of Veterinary Medicine under the supervision of Dr. Gus Kousoulas.

Four different nanoviricides showed greater...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Nanotechnology Business Journal
MSGI Enters Into Partnership Agreement With NASA., August 24, 2009
Arrowhead Announces Completion of $2.76 Million Private Placement., August 24, 2009
BioMimetic Therapeutics, Inc. to Present at the Canaccord Adams Global..., August 24, 2009

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.